Data on Materiality(Governance)Materiality (Material Issues)
Data on Materiality Strengthen corporate governance
In April 2021, an outside director was appointed from the pharmaceutical industry, and in August 2021, a designated compensation committee chaired by an independent outside director was established.
- 2014
- 2016
- 2017
- 2018
- 2019
- 2020
- 2021
- 2022
- 2023
- 2024
-
President
-
2014: Appointment of Tomiya Takamatsu as president
-
-
Group
structure-
2017: Transition to holding company structure
-
2020: Formation of a Group ESG Committee（currently:Group Sustainability Committee ）
-
-
Revitalizing
the Board
of
Directors
and
strengthening
its functions-
2016: Review of the scope of authority2017: Transffer of authority to group companies
-
The number of members on the Board of Directors as determined in the Artickes of Inc corporation to 9 to fewer2016: The number of members on the Board of Directors as determined in the Artickes of Inc corporation to 7 to fewer
-
2019: Formation of an Advisory Board
-
-
Improving
the
effectiveness
of the
Board of
Directors-
2017: Introduction of a performance-based incentive program2021：Formation of a Nominating and Compensation Committee
-
2016: Evaluation of the effectiveness of the Board of Directors
-
2017: Disclosure of a summary of the evaluation results
-
-
Outside
directors
(the number of people)-
2014: Apppintment of two outside directors
-
2016: two of six2021: three of six2022: four of seven
-
-
Outside
directors
(ratio)-
2016: 33.3%2021: 50%2022: 57.1%
-
-
Company
philosophy-
2014: Enactment of a new group philosophy,vision,and slogan
-
2016: Enactment of a corporate governance basic policy
-
2019: Enactment of a Group Code of Conduct
-
2023: Name changed from Group Slogan to Brand Message
-
Corporate Governance System
